Back to search
Monogenic Diabetes
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Monogenic Diabetes trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Monogenic Diabetes trials you may qualify forEvaluating a novel, allosteric glucokinase activator in monogenic diabetes secondary to inactivating glucokinase mutations: a randomised, cross-over trial
This observational study aims to establish a digital registry, screening platform for patients with monogenic diabetes using internet-based and mobile applicati…
This study evaluates the efficacy of sequential transplantation of umbilical cord blood stem cells and islet cells in children with monogenic immunodeficiency t…
This observational 'recruit by genotype' study aims to provide insights into the cellular and molecular pathways underlying beta cell disorders and their physio…
Type 1 diabetes (T1D) results from destruction of insulin-producing beta cells in the pancreas by the body's own immune system (autoimmunity). It is not fully u…
The goal of this observational study is to establish a registry, screening, and individualized management platform for patients with monogenic diabetes mellitus…
Genetics variants could be involved in atypical non-autoimmune diabetes revealed by ketoacidosis. The objective of this research will be to determine the relati…
This cross-sectional study aims to further subdivide diabetes mellitus into more homogeneous subgroups by focusing on extreme glucose metabolism phenotypes, inc…
Type 1 Diabetes is a multifactorial disease, with a strong genetic contribution of HLA genes, and minor contributions of many additional genes. The investigator…